{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:36:38Z","timestamp":1793406998578,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00894-020-04663-3","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:08:02Z","timestamp":1610222882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9611-7147","authenticated-orcid":false,"given":"Kehinde F.","family":"Omolabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9554-016X","authenticated-orcid":false,"given":"Emmanuel A.","family":"Iwuchukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-8031","authenticated-orcid":false,"given":"Clement","family":"Agoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-5983","authenticated-orcid":false,"given":"Fisayo A.","family":"Olotu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8711-7783","authenticated-orcid":false,"given":"Mahmoud E. S.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"4663_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/CMR.4.3.325","volume":"4","author":"WL Current","year":"1991","unstructured":"Current WL, Garcia LS (1991) Cryptosporidiosis. Clin Microbiol Rev 4:325\u2013358","journal-title":"Clin Microbiol Rev"},{"key":"4663_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/CMR.12.4.554","volume":"12","author":"DP Clark","year":"1999","unstructured":"Clark DP (1999) New insights into human cryptosporidiosis. Clin Microbiol Rev 12:554\u2013563","journal-title":"Clin Microbiol Rev"},{"key":"4663_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/QCO.0b013e328357e569","volume":"25","author":"D-AT Shirley","year":"2012","unstructured":"Shirley D-AT, Moonah SN, Kotloff KL (2012) Burden of disease from cryptosporidiosis. Curr Opin Infect Dis 25:555\u2013563. https:\/\/doi.org\/10.1097\/QCO.0b013e328357e569","journal-title":"Curr Opin Infect Dis"},{"key":"4663_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","volume":"15","author":"W Checkley","year":"2015","unstructured":"Checkley W, White Jr AC, Jaganath D (2015) A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis 15:85\u201394","journal-title":"Lancet Infect Dis"},{"key":"4663_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4269\/ajtmh.1999.60.157","volume":"60","author":"CL Chappell","year":"1999","unstructured":"Chappell CL, Okhuysen PC, Sterling CR et al (1999) Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg 60:157\u2013164. https:\/\/doi.org\/10.4269\/ajtmh.1999.60.157","journal-title":"Am J Trop Med Hyg"},{"key":"4663_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199407213310304","volume":"331","author":"WR Mac Kenzie","year":"1994","unstructured":"Mac Kenzie WR, Hoxie NJ, Proctor ME et al (1994) A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 331:161\u2013167. https:\/\/doi.org\/10.1056\/NEJM199407213310304","journal-title":"N Engl J Med"},{"key":"4663_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.307.6901.417","volume":"307","author":"K Molbak","year":"1993","unstructured":"Molbak K, Hojlyng N, Gottschau A et al (1993) Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, West Africa. Br Med J 307:417\u2013420. https:\/\/doi.org\/10.1136\/bmj.307.6901.417","journal-title":"Br Med J"},{"key":"4663_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff KL, Nataro JP, Blackwelder WC et al (2013) Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case\u2013control study. Lancet 382:209\u2013222. https:\/\/doi.org\/10.1016\/S0140-6736(13)60844-2","journal-title":"Lancet"},{"key":"4663_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/314820","volume":"180","author":"RD Newman","year":"1999","unstructured":"Newman RD, Sears CL, Moore SR et al (1999) Longitudinal study of Cryptosporidium infection in children in northeastern Brazil. J Infect Dis 180:167\u2013175. https:\/\/doi.org\/10.1086\/314820","journal-title":"J Infect Dis"},{"key":"4663_CR10","doi-asserted-by":"publisher","unstructured":"Khan A, Shams S, Khan S et al (2019) Evaluation of prevalence and risk factors associated with Cryptosporidium infection in rural population of district Buner, Pakistan. PLoS One 14. https:\/\/doi.org\/10.1371\/journal.pone.0209188","DOI":"10.1371\/journal.pone.0209188"},{"key":"4663_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2111-y","volume":"10","author":"SA Squire","year":"2017","unstructured":"Squire SA, Ryan U (2017) Cryptosporidium and Giardia in Africa: current and future challenges. Parasit Vectors 10:1\u201332. https:\/\/doi.org\/10.1186\/s13071-017-2111-y","journal-title":"Parasit Vectors"},{"key":"4663_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/TP.TP_25_17","volume":"7","author":"K Vanathy","year":"2017","unstructured":"Vanathy K, Parija SC, Mandal J et al (2017) Cryptosporidiosis: a mini review. Trop Parasitol 7:72. https:\/\/doi.org\/10.4103\/TP.TP_25_17","journal-title":"Trop Parasitol"},{"key":"4663_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40475-015-0056-9","volume":"2","author":"H Sparks","year":"2015","unstructured":"Sparks H, Nair G, Castellanos-Gonzalez A, White AC (2015) Treatment of Cryptosporidium: what we know, gaps, and the way forward. Curr Trop Med Reports 2:181\u2013187. https:\/\/doi.org\/10.1007\/s40475-015-0056-9","journal-title":"Curr Trop Med Reports"},{"key":"4663_CR14","doi-asserted-by":"publisher","unstructured":"Amadi B, Mwiya M, Sianongo S et al (2009) High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis:9. https:\/\/doi.org\/10.1186\/1471-2334-9-195","DOI":"10.1186\/1471-2334-9-195"},{"key":"4663_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1179\/joc.1999.11.5.391","volume":"11","author":"M Amenta","year":"1999","unstructured":"Amenta M, Dalle Nogare ER, Colomba C et al (1999) Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections. J Chemother 11:391\u2013395. https:\/\/doi.org\/10.1179\/joc.1999.11.5.391","journal-title":"J Chemother"},{"key":"4663_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0022-3476(96)70258-5","volume":"129","author":"P Hicks","year":"1996","unstructured":"Hicks P, Zwiener RJ, Squires J, Savell V (1996) Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr 129:297\u2013300. https:\/\/doi.org\/10.1016\/S0022-3476(96)70258-5","journal-title":"J Pediatr"},{"key":"4663_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0b013e31817beb78","volume":"48","author":"JC Gathe","year":"2008","unstructured":"Gathe JC, Mayberry C, Clemmons J, Nemecek J (2008) Resolution of severe cryptosporidial diarrhea with rifaximin in patients with AIDS. J Acquir Immune Defic Syndr 48:365\u2013366","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4663_CR18","unstructured":"Paromomycin oral\u00a0: uses, side effects, interactions, pictures, warnings & dosing\u2014WebMD. https:\/\/www.webmd.com\/drugs\/2\/drug-5160\/paromomycin-oral\/details#side-effects. Accessed 28 Jun 2020"},{"key":"4663_CR19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1086\/515352","volume":"178","author":"NH Smith","year":"1998","unstructured":"Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr (1998) Combination Drug Therapy for Cryptosporidiosis in AIDS. J Infect Dis 178:900\u2013903. https:\/\/doi.org\/10.1086\/515352","journal-title":"J Infect Dis"},{"key":"4663_CR20","doi-asserted-by":"publisher","first-page":"40320","DOI":"10.1074\/jbc.M407121200","volume":"279","author":"NN Umejiego","year":"2004","unstructured":"Umejiego NN, Li C, Riera T et al (2004) Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design. J Biol Chem 279:40320\u201340327. https:\/\/doi.org\/10.1074\/jbc.M407121200","journal-title":"J Biol Chem"},{"key":"4663_CR21","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1021\/jm3007917","volume":"55","author":"SK Gorla","year":"2012","unstructured":"Gorla SK, Kavitha M, Zhang M et al (2012) Selective and potent urea inhibitors of cryptosporidium parvum inosine 5\u2032-monophosphate dehydrogenase. J Med Chem 55:7759\u20137771. https:\/\/doi.org\/10.1021\/jm3007917","journal-title":"J Med Chem"},{"key":"4663_CR22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1128\/AAC.02075-13","volume":"58","author":"SK Gorla","year":"2014","unstructured":"Gorla SK, McNair NN, Yang G et al (2014) Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother 58:1603\u20131614. https:\/\/doi.org\/10.1128\/AAC.02075-13","journal-title":"Antimicrob Agents Chemother"},{"key":"4663_CR23","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1021\/jm400241j","volume":"56","author":"SK Gorla","year":"2013","unstructured":"Gorla SK, Kavitha M, Zhang M et al (2013) Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5\u2032-monophosphate dehydrogenase. J Med Chem 56:4028\u20134043. https:\/\/doi.org\/10.1021\/jm400241j","journal-title":"J Med Chem"},{"key":"4663_CR24","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bmcl.2012.12.037","volume":"23","author":"CR Johnson","year":"2013","unstructured":"Johnson CR, Gorla SK, Kavitha M et al (2013) Phthalazinone inhibitors of inosine-5\u2032-monophosphate dehydrogenase from Cryptosporidium parvum. Bioorg Med Chem Lett 23:1004\u20131007. https:\/\/doi.org\/10.1016\/j.bmcl.2012.12.037","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.bmcl.2012.01.029","volume":"22","author":"S Kirubakaran","year":"2012","unstructured":"Kirubakaran S, Gorla SK, Sharling L et al (2012) Structure\u2013activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. Bioorg Med Chem Lett 22:1985\u20131988. https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.029","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR26","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1021\/ja909947a","volume":"132","author":"IS Macpherson","year":"2010","unstructured":"Macpherson IS, Kirubakaran S, Gorla SK et al (2010) The structural basis of Cryptosporidium-specific IMP dehydrogenase inhibitor selectivity. J Am Chem Soc 132:1230\u20131231. https:\/\/doi.org\/10.1021\/ja909947a","journal-title":"J Am Chem Soc"},{"key":"4663_CR27","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1021\/jm900410u","volume":"52","author":"SK Maurya","year":"2009","unstructured":"Maurya SK, Gollapalli DR, Kirubakaran S et al (2009) Triazole inhibitors of Cryptosporidium parvum inosine 5\u2032-monophosphate dehydrogenase. J Med Chem 52:4623\u20134630. https:\/\/doi.org\/10.1021\/jm900410u","journal-title":"J Med Chem"},{"key":"4663_CR28","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1371\/journal.pntd.0000794","volume":"4","author":"L Sharling","year":"2010","unstructured":"Sharling L, Liu X, Gollapalli DR et al (2010) A screening pipeline for antiparasitic agents targeting Cryptosporidium inosine monophosphate dehydrogenase. PLoS Negl Trop Dis 4:e794. https:\/\/doi.org\/10.1371\/journal.pntd.0000794","journal-title":"PLoS Negl Trop Dis"},{"key":"4663_CR29","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1021\/jm501527z","volume":"57","author":"Z Sun","year":"2014","unstructured":"Sun Z, Khan J, Makowska-Grzyska M et al (2014) Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5\u2032-monophosphate dehydrogenase (CpIMPDH) inhibitors. J Med Chem 57:10544\u201310550. https:\/\/doi.org\/10.1021\/jm501527z","journal-title":"J Med Chem"},{"key":"4663_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.chembiol.2007.12.010","volume":"15","author":"NN Umejiego","year":"2008","unstructured":"Umejiego NN, Gollapalli D, Sharling L et al (2008) Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Biol 15:70\u201377. https:\/\/doi.org\/10.1016\/j.chembiol.2007.12.010","journal-title":"Chem Biol"},{"key":"4663_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2053230X15000187","volume":"71","author":"Y Kim","year":"2015","unstructured":"Kim Y, Makowska-Grzyska M, Gorla SK et al (2015) Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity. Acta Crystallogr Sect F Struct Biol Commun 71:531\u2013538. https:\/\/doi.org\/10.1107\/S2053230X15000187","journal-title":"Acta Crystallogr Sect F Struct Biol Commun"},{"key":"4663_CR32","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1074\/jbc.M114.619767","volume":"290","author":"M Makowska-Grzyska","year":"2015","unstructured":"Makowska-Grzyska M, Kim Y, Maltseva N et al (2015) A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity. J Biol Chem 290:5893\u20135911. https:\/\/doi.org\/10.1074\/jbc.M114.619767","journal-title":"J Biol Chem"},{"key":"4663_CR33","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1021\/cr900021w","volume":"109","author":"L Hedstrom","year":"2009","unstructured":"Hedstrom L (2009) IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev 109:2903\u20132928. https:\/\/doi.org\/10.1021\/cr900021w","journal-title":"Chem Rev"},{"key":"4663_CR34","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.bmc.2011.01.042","volume":"19","author":"K Felczak","year":"2011","unstructured":"Felczak K, Chen L, Wilson D et al (2011) Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain. Bioorg Med Chem 19:1594\u20131605. https:\/\/doi.org\/10.1016\/j.bmc.2011.01.042","journal-title":"Bioorg Med Chem"},{"key":"4663_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1749-6632.1993.tb17143.x","volume":"696","author":"AC Allison","year":"1993","unstructured":"Allison AC, Kowalski WJ, Muller CD, Eugui EM (1993) Mechanisms of action of mycophenolic acid. Ann N Y Acad Sci 696:63\u201387. https:\/\/doi.org\/10.1111\/j.1749-6632.1993.tb17143.x","journal-title":"Ann N Y Acad Sci"},{"key":"4663_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85\u2013118. https:\/\/doi.org\/10.1016\/S0162-3109(00)00188-0","journal-title":"Immunopharmacology"},{"key":"4663_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1381612822666151125000550","volume":"22","author":"M Hassan Baig","year":"2016","unstructured":"Hassan Baig M, Ahmad K, Roy S et al (2016) Computer aided drug design: success and limitations. Curr Pharm Des 22:572\u2013581. https:\/\/doi.org\/10.2174\/1381612822666151125000550","journal-title":"Curr Pharm Des"},{"key":"4663_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/minf.201400157","volume":"34","author":"R Kaalia","year":"2015","unstructured":"Kaalia R, Kumar A, Srinivasan A, Ghosh I (2015) An ab initio method for designing multi-target specific pharmacophores using complementary interaction field of aspartic proteases. Mol Inform 34:380\u2013393. https:\/\/doi.org\/10.1002\/minf.201400157","journal-title":"Mol Inform"},{"key":"4663_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/JRLCR.S46843","volume":"7","author":"X Qing","year":"2014","unstructured":"Qing X, Lee XY, De Raeymaeker J et al (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J Receptor Ligand Channel Res 7:81\u201392. https:\/\/doi.org\/10.2147\/JRLCR.S46843","journal-title":"J Receptor Ligand Channel Res"},{"key":"4663_CR40","doi-asserted-by":"publisher","first-page":"22799","DOI":"10.3390\/molecules201219880","volume":"20","author":"T Kaserer","year":"2015","unstructured":"Kaserer T, Beck KR, Akram M et al (2015) Pharmacophore models and pharmacophore-based virtual screening: concepts and applications exemplified on hydroxysteroid dehydrogenases. Molecules 20:22799\u201322832. https:\/\/doi.org\/10.3390\/molecules201219880","journal-title":"Molecules"},{"key":"4663_CR41","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1021\/ci900263d","volume":"49","author":"O Dror","year":"2009","unstructured":"Dror O, Schneidman-Duhovny D, Inbar Y et al (2009) Novel approach for efficient pharmacophore-based virtual screening: method and applications. J Chem Inf Model 49:2333\u20132343. https:\/\/doi.org\/10.1021\/ci900263d","journal-title":"J Chem Inf Model"},{"key":"4663_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10822-006-9082-y","volume":"20","author":"NJ Richmond","year":"2006","unstructured":"Richmond NJ, Abrams CA, Wolohan PRN et al (2006) GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des 20:567\u2013587. https:\/\/doi.org\/10.1007\/s10822-006-9082-y","journal-title":"J Comput Aided Mol Des"},{"key":"4663_CR43","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF00124324","volume":"9","author":"G Jones","year":"1995","unstructured":"Jones G, Willett P, Glen RC (1995) A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J Comput Aided Mol Des 9:532\u2013549. https:\/\/doi.org\/10.1007\/BF00124324","journal-title":"J Comput Aided Mol Des"},{"key":"4663_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1021\/jm900817u","volume":"53","author":"AR Leach","year":"2010","unstructured":"Leach AR, Gillet VJ, Lewis RA, Taylor R (2010) Three-dimensional pharmacophore methods in drug discovery. J Med Chem 53:539\u2013558","journal-title":"J Med Chem"},{"key":"4663_CR45","doi-asserted-by":"publisher","unstructured":"Simulations B (2019) Learning the footprints and fingerprints: pharmacophore modeling in the discovery of potential drug candidates. https:\/\/doi.org\/10.3844\/jobsp.2019","DOI":"10.3844\/jobsp.2019"},{"key":"4663_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12195-015-0421-8","volume":"9","author":"HM Kumalo","year":"2016","unstructured":"Kumalo HM, Soliman ME (2016) Per-residue energy footprints-based pharmacophore modeling as an enhanced in silico approach in drug discovery: a case study on the identification of novel \u03b2-secretase1 (BACE1) inhibitors as anti-Alzheimer agents. Cell Mol Bioeng 9:175\u2013189. https:\/\/doi.org\/10.1007\/s12195-015-0421-8","journal-title":"Cell Mol Bioeng"},{"key":"4663_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.2147\/DDDT.S95533","volume":"10","author":"FN Cele","year":"2016","unstructured":"Cele FN, Ramesh M, Soliman MES (2016) Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents. Drug Des Dev Ther 10:1365\u20131377. https:\/\/doi.org\/10.2147\/DDDT.S95533","journal-title":"Drug Des Dev Ther"},{"key":"4663_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera \u2013 a visualization system for exploratory research and analysis. J Comput Chem 25:1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"4663_CR49","doi-asserted-by":"publisher","unstructured":"Eswar N, Webb B, Marti-Renom MA et al (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinforma Chapter 5:Unit-5.6. https:\/\/doi.org\/10.1002\/0471250953.bi0506s15","DOI":"10.1002\/0471250953.bi0506s15"},{"key":"4663_CR50","unstructured":"ZINCPharmer: pharmacophore search of the ZINC database. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3394271\/. Accessed 29 Apr 2020"},{"key":"4663_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/CI049714","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC \u2013 a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177. https:\/\/doi.org\/10.1021\/CI049714","journal-title":"J Chem Inf Model"},{"key":"4663_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:1\u201313. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"4663_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235\u2013249. https:\/\/doi.org\/10.1016\/S1056-8719(00)00107-6","journal-title":"J Pharmacol Toxicol Methods"},{"key":"4663_CR54","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1021\/jm101020z","volume":"53","author":"P Ripphausen","year":"2010","unstructured":"Ripphausen P, Nisius B, Peltason L, Bajorath J (2010) Quo vadis, virtual screening? A comprehensive survey of prospective applications. J Med Chem 53:8461\u20138467. https:\/\/doi.org\/10.1021\/jm101020z","journal-title":"J Med Chem"},{"key":"4663_CR55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334.AutoDock","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson A (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334.AutoDock","journal-title":"J Comput Chem"},{"key":"4663_CR56","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME et al (2016) Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 11:905\u2013919. https:\/\/doi.org\/10.1038\/nprot.2016.051","journal-title":"Nat Protoc"},{"key":"4663_CR57","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Ruth H, Lindstrom W et al (2009) Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"4663_CR58","unstructured":"Schr\u00f6dinger Release 2020-4: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2020"},{"key":"4663_CR59","doi-asserted-by":"publisher","unstructured":"Karthick V, Nagasundaram N, Doss CGP et al (2016) Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus. Infect Dis Poverty 5. https:\/\/doi.org\/10.1186\/s40249-016-0105-1","DOI":"10.1186\/s40249-016-0105-1"},{"key":"4663_CR60","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/J.COMPBIOMED.2018.05.012","volume":"98","author":"M Lawal","year":"2018","unstructured":"Lawal M, Olotu FA, Soliman MES (2018) Across the blood\u2013brain barrier: neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer\u2019s disease using bioinformatics and computational tools. Comput Biol Med 98:168\u2013177. https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2018.05.012","journal-title":"Comput Biol Med"},{"key":"4663_CR61","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4155\/fmc.11.63","volume":"3","author":"C Liao","year":"2011","unstructured":"Liao C, Sitzmann M, Pugliese A, Nicklaus MC (2011) Software and resources for computational medicinal chemistry. Future Med Chem 3:1057\u20131085","journal-title":"Future Med Chem"},{"key":"4663_CR62","unstructured":"Molinspiration Cheminformatics. https:\/\/www.molinspiration.com\/. Accessed 1 May 2020"},{"key":"4663_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/nar\/gku401","volume":"42","author":"MN Drwal","year":"2014","unstructured":"Drwal MN, Banerjee P, Dunkel M et al (2014) ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res 42:3\u20138. https:\/\/doi.org\/10.1093\/nar\/gku401","journal-title":"Nucleic Acids Res"},{"key":"4663_CR64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, Von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55:460\u2013473. https:\/\/doi.org\/10.1021\/ci500588j","journal-title":"J Chem Inf Model"},{"key":"4663_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12013-019-00896-z","volume":"78","author":"C Agoni","year":"2020","unstructured":"Agoni C, Munsamy G, Ramhrack P, Soliman M (2020) Human rhinovirus inhibition through capsid \u201ccanyon\u201d perturbation: structural insights into the role of a novel benzothiophene derivative. Cell Biochem Biophys 78:3\u201313","journal-title":"Cell Biochem Biophys"},{"key":"4663_CR66","doi-asserted-by":"publisher","unstructured":"Agoni C, Salifu EY, Munsamy G et al (2019) CF3-pyridinyl substitution on anti-malarial therapeutics: probing differential ligand binding and dynamical inhibitory effects of a novel triazolopyrimidine-based inhibitor on Plasmodium falciparum dihydroorotate dehydrogenase. Chem Biodivers. https:\/\/doi.org\/10.1002\/cbdv.201900365","DOI":"10.1002\/cbdv.201900365"},{"key":"4663_CR67","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jcb.27458","volume":"120","author":"FA Olotu","year":"2019","unstructured":"Olotu FA, Soliman MES (2019) Dynamic perspectives into the mechanisms of mutation-induced p53-DNA binding loss and inactivation using active perturbation theory: structural and molecular insights toward the design of potent reactivators in cancer therapy. J Cell Biochem 120:951\u2013966. https:\/\/doi.org\/10.1002\/jcb.27458","journal-title":"J Cell Biochem"},{"key":"4663_CR68","doi-asserted-by":"publisher","unstructured":"Nair PC, Miners JO (2014) Molecular dynamics simulations: from structure function relationships to drug discovery. Silico Pharmacol 2. https:\/\/doi.org\/10.1186\/s40203-014-0004-8","DOI":"10.1186\/s40203-014-0004-8"},{"key":"4663_CR69","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general Amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"4663_CR70","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1103\/PhysRevA.33.3628","volume":"33","author":"GS Grest","year":"1986","unstructured":"Grest GS, Kremer K (1986) Molecular dynamics simulation for polymers in the presence of a heat bath. Phys Rev A 33:3628\u20133631. https:\/\/doi.org\/10.1103\/PhysRevA.33.3628","journal-title":"Phys Rev A"},{"key":"4663_CR71","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen HJC, Postma JPM, Van Gunsteren WF et al (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684\u20133690. https:\/\/doi.org\/10.1063\/1.448118","journal-title":"J Chem Phys"},{"key":"4663_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"J-P Ryckaert","year":"1977","unstructured":"Ryckaert J-P, Ciccotti G, Berendsen HJC (1977) Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327\u2013341. https:\/\/doi.org\/10.1016\/0021-9991(77)90098-5","journal-title":"J Comput Phys"},{"key":"4663_CR73","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9:3084\u20133095. https:\/\/doi.org\/10.1021\/ct400341p","journal-title":"J Chem Theory Comput"},{"key":"4663_CR74","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1021\/ci500161d","volume":"54","author":"E Seifert","year":"2014","unstructured":"Seifert E (2014) OriginPro 9.1: scientific data analysis and graphing software\u2014software review. J Chem Inf Model 54:1552. https:\/\/doi.org\/10.1021\/ci500161d","journal-title":"J Chem Inf Model"},{"key":"4663_CR75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discovery 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discovery"},{"key":"4663_CR76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51:69\u201382. https:\/\/doi.org\/10.1021\/ci100275a","journal-title":"J Chem Inf Model"},{"key":"4663_CR77","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/07391102.2016.1165736","volume":"35","author":"N Chaudhary","year":"2017","unstructured":"Chaudhary N, Aparoy P (2017) Deciphering the mechanism behind the varied binding activities of COXIBs through molecular dynamic simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies. J Biomol Struct Dyn 35:868\u2013882. https:\/\/doi.org\/10.1080\/07391102.2016.1165736","journal-title":"J Biomol Struct Dyn"},{"key":"4663_CR78","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijbiomac.2018.07.050","volume":"119","author":"A Gupta","year":"2018","unstructured":"Gupta A, Chaudhary N, Aparoy P (2018) MM-PBSA and per-residue decomposition energy studies on 7-phenyl-imidazoquinolin-4(5H)-one derivatives: identification of crucial site points at microsomal prostaglandin E synthase-1 (mPGES-1) active site. Int J Biol Macromol 119:352\u2013359. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.07.050","journal-title":"Int J Biol Macromol"},{"key":"4663_CR79","volume-title":"Amber 18","author":"DA Case","year":"2018","unstructured":"Case DA (2018) Amber 18. Univ California, San Francisco"},{"key":"4663_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/c3fd00125c","volume":"169","author":"CJ Woods","year":"2014","unstructured":"Woods CJ, Malaisree M, Michel J et al (2014) Rapid decomposition and visualisation of protein\u2013ligand binding free energies by residue and by water. Faraday Discuss 169:477\u2013499. https:\/\/doi.org\/10.1039\/c3fd00125c","journal-title":"Faraday Discuss"},{"key":"4663_CR81","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nature03197","volume":"432","author":"BK Shoichet","year":"2004","unstructured":"Shoichet BK (2004) Virtual screening of chemical libraries. Nature 432:862\u2013865","journal-title":"Nature"},{"key":"4663_CR82","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrd1110","volume":"2","author":"T Kenakin","year":"2003","unstructured":"Kenakin T (2003) Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2:429\u2013438","journal-title":"Nat Rev Drug Discov"},{"key":"4663_CR83","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jmr.744","volume":"18","author":"W Huber","year":"2005","unstructured":"Huber W (2005) A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound\u2013target interactions. J Mol Recognit 18:273\u2013281. https:\/\/doi.org\/10.1002\/jmr.744","journal-title":"J Mol Recognit"},{"key":"4663_CR84","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE, Darden T, Gohlke H, Luo R et al (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668\u20131688","journal-title":"J Comput Chem"},{"key":"4663_CR85","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/prot.23018","volume":"79","author":"T Yang","year":"2011","unstructured":"Yang T, Wu JC, Yan C et al (2011) Virtual screening using molecular simulations. Proteins Struct Funct Bioinform 79:1940\u20131951. https:\/\/doi.org\/10.1002\/prot.23018","journal-title":"Proteins Struct Funct Bioinform"},{"key":"4663_CR86","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1002\/jcc.21758","volume":"32","author":"HG Wallnoefer","year":"2011","unstructured":"Wallnoefer HG, Liedl KR, Fox T (2011) A challenging system: free energy prediction for factor Xa. J Comput Chem 32:1743\u20131752. https:\/\/doi.org\/10.1002\/jcc.21758","journal-title":"J Comput Chem"},{"key":"4663_CR87","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1021\/jm0608210","volume":"49","author":"A Weis","year":"2006","unstructured":"Weis A, Katebzadeh K, S\u00f6derhjelm P et al (2006) Ligand affinities predicted with the MM\/PBSA method: dependence on the simulation method and the force field. J Med Chem 49:6596\u20136606. https:\/\/doi.org\/10.1021\/jm0608210","journal-title":"J Med Chem"},{"key":"4663_CR88","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1073\/pnas.0304686101","volume":"101","author":"B Striepen","year":"2004","unstructured":"Striepen B, Pruijssers AJP, Huang J et al (2004) Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc Natl Acad Sci U S A 101:3154\u20133159. https:\/\/doi.org\/10.1073\/pnas.0304686101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4663_CR89","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.2174\/092986711795590129","volume":"18","author":"L Hedstrom","year":"2011","unstructured":"Hedstrom L, Liechti G, Goldberg JB, Gollapalli DR (2011) The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Curr Med Chem 18:1909\u20131918. https:\/\/doi.org\/10.2174\/092986711795590129","journal-title":"Curr Med Chem"},{"key":"4663_CR90","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.drudis.2006.06.013","volume":"11","author":"IV Tetko","year":"2006","unstructured":"Tetko IV, Bruneau P, Mewes H-W et al (2006) Can we estimate the accuracy of ADME\u2013Tox predictions? Drug Discov 11:700\u2013707. https:\/\/doi.org\/10.1016\/j.drudis.2006.06.013","journal-title":"Drug Discov"},{"key":"4663_CR91","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"4663_CR92","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"JA Arnott","year":"2012","unstructured":"Arnott JA, Planey SL (2012) The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discovery 7:863\u2013875. https:\/\/doi.org\/10.1517\/17460441.2012.714363","journal-title":"Expert Opin Drug Discovery"},{"key":"4663_CR93","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","volume":"28","author":"X Liu","year":"2011","unstructured":"Liu X, Testa B, Fahr A (2011) Lipophilicity and its relationship with passive drug permeation. Pharm Res 28:962\u2013977","journal-title":"Pharm Res"},{"key":"4663_CR94","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881\u2013890. https:\/\/doi.org\/10.1038\/nrd2445","journal-title":"Nat Rev Drug Discov"},{"key":"4663_CR95","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.bmcl.2009.03.109","volume":"19","author":"MJ Waring","year":"2009","unstructured":"Waring MJ (2009) Defining optimum lipophilicity and molecular weight ranges for drug candidates\u2014molecular weight dependent lower log D limits based on permeability. Bioorg Med Chem Lett 19:2844\u20132851. https:\/\/doi.org\/10.1016\/j.bmcl.2009.03.109","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd3367","volume":"10","author":"MP Gleeson","year":"2011","unstructured":"Gleeson MP, Hersey A, Montanari D, Overington J (2011) Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov 10:197\u2013208. https:\/\/doi.org\/10.1038\/nrd3367","journal-title":"Nat Rev Drug Discov"},{"key":"4663_CR97","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","volume":"18","author":"JD Hughes","year":"2008","unstructured":"Hughes JD, Blagg J, Price DA et al (2008) Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 18:4872\u20134875. https:\/\/doi.org\/10.1016\/j.bmcl.2008.07.071","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR98","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1016\/j.bmcl.2010.06.129","volume":"20","author":"N Greene","year":"2010","unstructured":"Greene N, Aleo MD, Louise-May S et al (2010) Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies. Bioorg Med Chem Lett 20:5308\u20135312. https:\/\/doi.org\/10.1016\/j.bmcl.2010.06.129","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR99","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1517\/17425250903042318","volume":"5","author":"DA Price","year":"2009","unstructured":"Price DA, Blagg J, Jones L et al (2009) Physicochemical drug properties associated with in vivo toxicological outcomes: a review. Expert Opin Drug Metab Toxicol 5:921\u2013931","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"4663_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040654","volume":"7","author":"SSSJ Ahmed","year":"2012","unstructured":"Ahmed SSSJ, Ramakrishnan V (2012) Systems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability prediction. PLoS One 7:e40654. https:\/\/doi.org\/10.1371\/journal.pone.0040654","journal-title":"PLoS One"},{"key":"4663_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrd4163","volume":"13","author":"AL Hopkins","year":"2014","unstructured":"Hopkins AL, Keser\u00fc GM, Leeson PD et al (2014) The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 13:105\u2013121. https:\/\/doi.org\/10.1038\/nrd4163","journal-title":"Nat Rev Drug Discov"},{"key":"4663_CR102","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","volume":"9","author":"AL Hopkins","year":"2004","unstructured":"Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430\u2013431","journal-title":"Drug Discov Today"},{"key":"4663_CR103","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1359-6446(05)03511-7","volume":"10","author":"RAE Carr","year":"2005","unstructured":"Carr RAE, Congreve M, Murray CW, Rees DC (2005) Fragment-based lead discovery: leads by design. Drug Discov Today 10:987\u2013992","journal-title":"Drug Discov Today"},{"key":"4663_CR104","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10822-011-9435-z","volume":"25","author":"PN Mortenson","year":"2011","unstructured":"Mortenson PN, Murray CW (2011) Assessing the lipophilicity of fragments and early hits. J Comput Aided Mol Des 25:663\u2013667. https:\/\/doi.org\/10.1007\/s10822-011-9435-z","journal-title":"J Comput Aided Mol Des"},{"key":"4663_CR105","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.drudis.2008.11.007","volume":"14","author":"SD Bembenek","year":"2009","unstructured":"Bembenek SD, Tounge BA, Reynolds CH (2009) Ligand efficiency and fragment-based drug discovery. Drug Discov Today 14:278\u2013283","journal-title":"Drug Discov Today"},{"key":"4663_CR106","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1021\/ci900094m","volume":"49","author":"JWM Nissink","year":"2009","unstructured":"Nissink JWM (2009) Simple size-independent measure of ligand efficiency. J Chem Inf Model 49:1617\u20131622. https:\/\/doi.org\/10.1021\/ci900094m","journal-title":"J Chem Inf Model"},{"key":"4663_CR107","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/jm701255b","volume":"51","author":"CH Reynolds","year":"2008","unstructured":"Reynolds CH, Tounge BA, Bembenek SD (2008) Ligand binding efficiency: trends, physical basis, and implications. J Med Chem 51:2432\u20132438. https:\/\/doi.org\/10.1021\/jm701255b","journal-title":"J Med Chem"},{"key":"4663_CR108","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1016\/j.bmcl.2009.05.062","volume":"19","author":"T Ryckmans","year":"2009","unstructured":"Ryckmans T, Edwards MP, Horne VA et al (2009) Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis. Bioorg Med Chem Lett 19:4406\u20134409. https:\/\/doi.org\/10.1016\/j.bmcl.2009.05.062","journal-title":"Bioorg Med Chem Lett"},{"key":"4663_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl P, Schuffenhauer A (2009) Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 1:8. https:\/\/doi.org\/10.1186\/1758-2946-1-8","journal-title":"J Cheminform"},{"key":"4663_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05964-z","volume":"7","author":"A Bahmani","year":"2017","unstructured":"Bahmani A, Saaidpour S, Rostami A (2017) A simple, robust and efficient computational method for n-octanol\/water partition coefficients of substituted aromatic drugs. Sci Rep 7:1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-05964-z","journal-title":"Sci Rep"},{"key":"4663_CR111","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714\u20133717. https:\/\/doi.org\/10.1021\/jm000942e","journal-title":"J Med Chem"},{"key":"4663_CR112","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/jm801389m","volume":"52","author":"J Fernandes","year":"2009","unstructured":"Fernandes J, Gattass CR (2009) Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1\/ABCC1). J Med Chem 52:1214\u20131218. https:\/\/doi.org\/10.1021\/jm801389m","journal-title":"J Med Chem"},{"key":"4663_CR113","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/092986709787002817","volume":"16","author":"S Prasanna","year":"2008","unstructured":"Prasanna S, Doerksen R (2008) Topological polar surface area: a useful descriptor in 2D-QSAR. Curr Med Chem 16:21\u201341. https:\/\/doi.org\/10.2174\/092986709787002817","journal-title":"Curr Med Chem"},{"key":"4663_CR114","first-page":"876","volume":"8","author":"M Congreve","year":"2003","unstructured":"Congreve M, Carr R, Murray C, Jhoti H (2003) A \u201crule of three\u201d for fragment-based lead discovery? Drug Discov. Today 8:876\u2013877","journal-title":"Today"},{"key":"4663_CR115","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1080\/07391102.2018.1546621","volume":"37","author":"M Gulzar","year":"2019","unstructured":"Gulzar M, Ali S, Khan F et al (2019) Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies. J Biomol Struct Dyn 37:4327\u20134337","journal-title":"J Biomol Struct Dyn"},{"key":"4663_CR116","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12013-018-0852-7","volume":"76","author":"KE Machaba","year":"2018","unstructured":"Machaba KE, Mhlongo NN, Soliman MES (2018) Induced Mutation Proves a Potential Target for TB Therapy: A Molecular Dynamics Study on LprG. Cell Biochem Biophys 76:345\u2013356. https:\/\/doi.org\/10.1007\/s12013-018-0852-7","journal-title":"Cell Biochem Biophys"},{"key":"4663_CR117","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1021\/jp412776d","volume":"118","author":"JW Pitera","year":"2014","unstructured":"Pitera JW (2014) Expected distributions of root-mean-square positional deviations in proteins. J Phys Chem B 118:6526\u20136530. https:\/\/doi.org\/10.1021\/jp412776d","journal-title":"J Phys Chem B"},{"key":"4663_CR118","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/prot.10250","volume":"50","author":"R Br\u00fcschweiler","year":"2002","unstructured":"Br\u00fcschweiler R (2002) Efficient RMSD measures for the comparison of two molecular ensembles. Proteins Struct Funct Bioinform 50:26\u201334. https:\/\/doi.org\/10.1002\/prot.10250","journal-title":"Proteins Struct Funct Bioinform"},{"key":"4663_CR119","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/prot.20434","volume":"59","author":"M Kr\u00f3l","year":"2005","unstructured":"Kr\u00f3l M, Roterman I, Piekarska B et al (2005) Analysis of correlated domain motions in IgG light chain reveals possible mechanisms of immunological signal transduction. Proteins Struct Funct Genet 59:545\u2013554. https:\/\/doi.org\/10.1002\/prot.20434","journal-title":"Proteins Struct Funct Genet"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-020-04663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-020-04663-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-020-04663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T14:26:40Z","timestamp":1613312800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-020-04663-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4663"],"URL":"https:\/\/doi.org\/10.1007\/s00894-020-04663-3","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"12 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}